Vyne Therapeutics Stock Market Value
| VYNE Stock | USD 1.85 0.05 2.63% |
| Symbol | Vyne |
Vyne Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vyne Therapeutics. If investors know Vyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 1.72 | Revenue Per Share | Quarterly Revenue Growth 0.467 | Return On Assets | Return On Equity |
The market value of Vyne Therapeutics is measured differently than its book value, which is the value of Vyne that is recorded on the company's balance sheet. Investors also form their own opinion of Vyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vyne Therapeutics' market value can be influenced by many factors that don't directly affect Vyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vyne Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vyne Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vyne Therapeutics.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Vyne Therapeutics on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Vyne Therapeutics or generate 0.0% return on investment in Vyne Therapeutics over 90 days. Vyne Therapeutics is related to or competes with Akari Therapeutics, Salarius Pharmaceuticals, SAB Biotherapeutics, GeoVax Labs, Unicycive Therapeutics, Pulmatrix, and Cidara Therapeutics. VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno... More
Vyne Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vyne Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vyne Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 28.11 | |||
| Value At Risk | (8.94) | |||
| Potential Upside | 7.14 |
Vyne Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vyne Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vyne Therapeutics' standard deviation. In reality, there are many statistical measures that can use Vyne Therapeutics historical prices to predict the future Vyne Therapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | 0.5869 | |||
| Treynor Ratio | (0.47) |
Vyne Therapeutics Backtested Returns
Vyne Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0726, which indicates the firm had a -0.0726 % return per unit of risk over the last 3 months. Vyne Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vyne Therapeutics' Coefficient Of Variation of (1,740), variance of 28.89, and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide. The entity has a beta of 0.67, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Vyne Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Vyne Therapeutics is expected to be smaller as well. At this point, Vyne Therapeutics has a negative expected return of -0.39%. Please make sure to validate Vyne Therapeutics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Vyne Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.46 |
Average predictability
Vyne Therapeutics has average predictability. Overlapping area represents the amount of predictability between Vyne Therapeutics time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vyne Therapeutics price movement. The serial correlation of 0.46 indicates that about 46.0% of current Vyne Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Vyne Therapeutics lagged returns against current returns
Autocorrelation, which is Vyne Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vyne Therapeutics' stock expected returns. We can calculate the autocorrelation of Vyne Therapeutics returns to help us make a trade decision. For example, suppose you find that Vyne Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vyne Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vyne Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vyne Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vyne Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Vyne Therapeutics Lagged Returns
When evaluating Vyne Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vyne Therapeutics stock have on its future price. Vyne Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vyne Therapeutics autocorrelation shows the relationship between Vyne Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Vyne Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vyne Therapeutics is a strong investment it is important to analyze Vyne Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vyne Therapeutics' future performance. For an informed investment choice regarding Vyne Stock, refer to the following important reports:Check out Vyne Therapeutics Correlation, Vyne Therapeutics Volatility and Vyne Therapeutics Alpha and Beta module to complement your research on Vyne Therapeutics. For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Vyne Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.